Belka C - Search Results

1

Validation of the prognostic Heidelberg re-irradiation score in an independent mono-institutional patient cohort.

Niyazi M, Flieger M, Ganswindt U, Combs SE, Belka C. Niyazi M, et al. Among authors: belka c. Radiat Oncol. 2014 Jun 3;9:128. doi: 10.1186/1748-717X-9-128. Radiat Oncol. 2014. PMID: 24893775 Free PMC article. Clinical Trial.

2

Reirradiation alternating with docetaxel and cisplatin in inoperable recurrence of head-and-neck cancer: a prospective phase I/II trial.

Hehr T, Classen J, Belka C, Welz S, Schäfer J, Koitschev A, Bamberg M, Budach W. Hehr T, et al. Among authors: belka c. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1423-31. doi: 10.1016/j.ijrobp.2004.08.020. Int J Radiat Oncol Biol Phys. 2005. PMID: 15817346 Clinical Trial.

3

70 Gy or more: which dose for which prostate cancer?

Ganswindt U, Paulsen F, Anastasiadis AG, Stenzl A, Bamberg M, Belka C. Ganswindt U, et al. Among authors: belka c. J Cancer Res Clin Oncol. 2005 Jul;131(7):407-19. doi: 10.1007/s00432-005-0681-0. Epub 2005 May 11. J Cancer Res Clin Oncol. 2005. PMID: 15887028 Review.

4

Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definition.

Ganswindt U, Paulsen F, Corvin S, Eichhorn K, Glocker S, Hundt I, Birkner M, Alber M, Anastasiadis A, Stenzl A, Bares R, Budach W, Bamberg M, Belka C. Ganswindt U, et al. Among authors: belka c. BMC Cancer. 2005 Jul 28;5:91. doi: 10.1186/1471-2407-5-91. BMC Cancer. 2005. PMID: 16048656 Free PMC article.

5

The membrane targeted apoptosis modulators erucylphosphocholine and erucylphosphohomocholine increase the radiation response of human glioblastoma cell lines in vitro.

Rübel A, Handrick R, Lindner LH, Steiger M, Eibl H, Budach W, Belka C, Jendrossek V. Rübel A, et al. Among authors: belka c. Radiat Oncol. 2006 Mar 29;1:6. doi: 10.1186/1748-717X-1-6. Radiat Oncol. 2006. PMID: 16722524 Free PMC article.

6

Combination of celecoxib with percutaneous radiotherapy in patients with localised prostate cancer - a phase I study.

Ganswindt U, Budach W, Jendrossek V, Becker G, Bamberg M, Belka C. Ganswindt U, et al. Among authors: belka c. Radiat Oncol. 2006 Apr 10;1:9. doi: 10.1186/1748-717X-1-9. Radiat Oncol. 2006. PMID: 16722607 Free PMC article. Clinical Trial.

7

[Recurrence of prostate cancer--value of salvage radiotherapy].

Belka C, Ganswindt U. Belka C, et al. Urologe A. 2006 Oct;45(10):1266-70. doi: 10.1007/s00120-006-1210-8. Urologe A. 2006. PMID: 17006699 Review. German.

8

Isobologram analysis of triple therapies.

Niyazi M, Belka C. Niyazi M, et al. Among authors: belka c. Radiat Oncol. 2006 Oct 17;1:39. doi: 10.1186/1748-717X-1-39. Radiat Oncol. 2006. PMID: 17044920 Free PMC article.

9

Counting colonies of clonogenic assays by using densitometric software.

Niyazi M, Niyazi I, Belka C. Niyazi M, et al. Among authors: belka c. Radiat Oncol. 2007 Jan 9;2:4. doi: 10.1186/1748-717X-2-4. Radiat Oncol. 2007. PMID: 17212832 Free PMC article.

10

The role of PDGF in radiation oncology.

Li M, Jendrossek V, Belka C. Li M, et al. Among authors: belka c. Radiat Oncol. 2007 Jan 11;2:5. doi: 10.1186/1748-717X-2-5. Radiat Oncol. 2007. PMID: 17217530 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

666 results

Search Page

Filters